Results of research sponsored by the National Rosacea Society (NRS) on cathelicidins as a causal factor in rosacea were recently published in Nature Medicine, a leading journal on biomedical science. News coverage of the study, including comments from the lead researcher Dr. Richard Gallo and NRS medical advisory board chairman Dr. Jonathan Wilkin, can be viewed here, and an abstract of the article is available here.
Weblog
Posted: 07/06/2007
New grants are available from the National Rosacea Society (NRS) in 2007 to support research into the potential causes and other key aspects of rosacea, a chronic and often life-disruptive disorder of the facial skin and eyes, now estimated to affect 14 million Americans. The awarding of five research grants totaling $125,000 was announced earlier this year.
Posted: 05/23/2007
The Spring 2007 issue of Rosacea Review is now online at rosacea.org.
Posted: 05/02/2007
New clues to help unlock the mystery of rosacea were identified in a recent study in which researchers used advanced technology to evaluate the skin of patients successfully treated with pulsed dye lasers (PDL) or intense pulsed light (IPL).
Posted: 04/02/2007
Danger Signs of Red-Faced Disorder Strike Millions of Adults at Any Age
Posted: 03/20/2007
As the National Rosacea Society (NRS) marks its 15th anniversary in 2007, we are pleased to report the immense progress that has been made in achieving our mission of improving the lives of people with rosacea through awareness, education and support of medical research on this widespread but poorly understood disorder.
Posted: 02/21/2007
The Winter 2007 issue of Rosacea Review is now available on rosacea.org.
Posted: 02/07/2007
Rosacea Awareness Month to Highlight Wide Prevalence of Chronic Condition
BARRINGTON, Illinois (February 7, 2007) -- More than 14 million Americans are estimated to suffer from rosacea, yet most of them fail to recognize it. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to alert the public to the warning signs of this embarrassing and potentially life-disruptive facial disorder, and to emphasize the importance of seeking medical help.
Posted: 01/15/2007
National Rosacea Society Awards New Grants for Rosacea Research
The National Rosacea Society (NRS) announced that five new studies have been awarded funding as part of its research grants program to advance scientific knowledge of the potential causes and other key aspects of this chronic and potentially life-disruptive disorder that affects an estimated 14 million Americans.
Posted: 01/05/2007
New Study Uncovers the Dark Side of ATP
Researchers have found that one of the most common and hard-working substances in the body may have a Jekyll and Hyde quality in rosacea patients, assuming a darker role when activated by flare-up triggers.
Posted: 10/16/2006
The Fall 2006 issue of Rosacea Review is now available on rosacea.org.
Posted: 08/28/2006
New Study Finds Allergy-like Reaction May Trigger Rosacea Bumps and Pimples
Posted: 07/25/2006
The following announcement was issued by CollaGenex Pharmaceuticals:
FIRST ORAL DRUG FOR ROSACEA
COLLAGENEX PHARMACEUTICALS
INTRODUCES ORACEA™
(doxycycline, USP) capsules 40 mg*
* 30 mg immediate release and 10 mg delayed release beads
Posted: 07/07/2006
The following announcement was issued by the National Women's Health Resource Center:
Do You Live in a Dry Eye Hot Spot?
Posted: 06/14/2006
Trail of Tears May Lead Scientists To First Diagnostic Test for Rosacea
Posted: 06/06/2006
The summer 2006 issue of Rosacea Review is now available on rosacea.org.
Posted: 05/05/2006
New Research Grants Available for Widespread Facial Disorder
BARRINGTON, Illinois (May 5, 2006) -- The National Rosacea Society today announced that new grants are available in 2006 to support research into the potential causes and other key aspects of rosacea, a chronic and often life-disruptive disorder of the facial skin and eyes, now estimated to affect 14 million Americans. The awarding of five research grants totaling $123,600 was announced earlier this year.
Posted: 04/03/2006
A Blush Can Signal Danger for Millions with Rosacea
CHICAGO (April 3, 2006) -- What at first may seem like an innocent blush or sunburn may ultimately foreshadow rosacea, a widespread but potentially serious facial disorder now estimated to affect more than 14 million Americans. April has been designated Rosacea Awareness Month to alert the public to the warning signs of this red-faced, acne-like condition, and to emphasize the importance of seeking medical help before it becomes increasingly intrusive on daily life.
Posted: 02/20/2006
Survey Shows Facial Disorder Hurts More Than Appearance
BARRINGTON, Illinois (February 20, 2006) -- While the often-devastating impact of rosacea on facial appearance is well recognized, a new survey shows that physical discomfort is also experienced by the majority of people with this red-faced, acne-like disorder now estimated to affect more than 14 million Americans.
Posted: 01/11/2006
New Research Grants Awarded to Further Knowledge of Rosacea
BARRINGTON, Illinois (January 11, 2006) -- The National Rosacea Society (NRS) announced that five new studies have been awarded funding as part of its research grants program to advance scientific knowledge of the potential causes and other key aspects of this chronic and potentially devastating disorder that affects an estimated 14 million Americans.
Pages
Contact Us
- Phone:
- 1-888-NO-BLUSH
- Email:
- rosaceas@aol.com
196 James St.
Barrington, IL 60010
Our Mission
The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace
consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.